Lindsay Strowd to Dermatitis, Atopic
This is a "connection" page, showing publications Lindsay Strowd has written about Dermatitis, Atopic.
Connection Strength
3.741
-
Hamid RN, Bomar L, Strowd L. Dupilumab for treatment of severe atopic dermatitis in a heart transplant recipient. Cutis. 2019 Jun; 103(6):E1-E2.
Score: 0.624
-
Ramachandran V, Cline A, Feldman SR, Strowd LC. Evaluating crisaborole as a treatment option for atopic dermatitis. Expert Opin Pharmacother. 2019 Jun; 20(9):1057-1063.
Score: 0.619
-
Edwards T, Patel NU, Blake A, Prabakaran S, Reimer D, Feldman SR, Strowd LC. Insights into future therapeutics for atopic dermatitis. Expert Opin Pharmacother. 2018 02; 19(3):265-278.
Score: 0.568
-
Shukla S, Feldman SR, Strowd LC. A safety review of the medications used to treat atopic dermatitis. Expert Opin Drug Saf. 2018 02; 17(2):179-183.
Score: 0.562
-
Strowd LC, Feldman SR. Dupilumab for atopic dermatitis. Lancet. 2017 06 10; 389(10086):2265-2266.
Score: 0.540
-
Patel N, Strowd LC. The Future of Atopic Dermatitis Treatment. Adv Exp Med Biol. 2017; 1027:185-210.
Score: 0.528
-
Glines KR, Stiff KM, Freeze M, Cline A, Strowd LC, Feldman SR. An update on the topical and oral therapy options for treating pediatric atopic dermatitis. Expert Opin Pharmacother. 2019 04; 20(5):621-629.
Score: 0.152
-
Seger EW, Wechter T, Strowd L, Feldman SR. Relative efficacy of systemic treatments for atopic dermatitis. J Am Acad Dermatol. 2019 Feb; 80(2):411-416.e4.
Score: 0.149